NO933153L - Fremgangsmåte for fremstilling av protease-inhibitorer - Google Patents

Fremgangsmåte for fremstilling av protease-inhibitorer

Info

Publication number
NO933153L
NO933153L NO933153A NO933153A NO933153L NO 933153 L NO933153 L NO 933153L NO 933153 A NO933153 A NO 933153A NO 933153 A NO933153 A NO 933153A NO 933153 L NO933153 L NO 933153L
Authority
NO
Norway
Prior art keywords
preparation
protease inhibitors
yeast strains
transformed yeast
deulfatohirudin
Prior art date
Application number
NO933153A
Other languages
English (en)
Norwegian (no)
Other versions
NO933153D0 (no
Inventor
Jutta Heim
Peter Furst
Thomas Hottiger
Jochen Kuhla
Gabriele Pohlig
Original Assignee
Ciba Geigy Ag
Ucp Gen Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag, Ucp Gen Pharma Ag filed Critical Ciba Geigy Ag
Publication of NO933153D0 publication Critical patent/NO933153D0/no
Publication of NO933153L publication Critical patent/NO933153L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
NO933153A 1992-09-04 1993-09-03 Fremgangsmåte for fremstilling av protease-inhibitorer NO933153L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92810681 1992-09-04

Publications (2)

Publication Number Publication Date
NO933153D0 NO933153D0 (no) 1993-09-03
NO933153L true NO933153L (no) 1994-03-07

Family

ID=8211979

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933153A NO933153L (no) 1992-09-04 1993-09-03 Fremgangsmåte for fremstilling av protease-inhibitorer

Country Status (20)

Country Link
US (1) US5726043A (de)
EP (2) EP1031628A1 (de)
JP (2) JP3949734B2 (de)
KR (1) KR940007180A (de)
AT (1) ATE196927T1 (de)
AU (1) AU675071B2 (de)
CA (1) CA2105425A1 (de)
DE (1) DE69329540T2 (de)
DK (1) DK0592358T3 (de)
ES (1) ES2152943T3 (de)
FI (1) FI933821A7 (de)
GR (1) GR3035201T3 (de)
HU (1) HU217094B (de)
IL (1) IL106897A0 (de)
MX (1) MX9305375A (de)
NO (1) NO933153L (de)
NZ (1) NZ248558A (de)
PT (1) PT592358E (de)
SG (1) SG49859A1 (de)
ZA (1) ZA936507B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990010008A (ko) * 1997-07-14 1999-02-05 구광시 효모용 프로모터 및 이 프로모터를 포함하는 효모용발현 벡터
US6358705B1 (en) 1998-07-16 2002-03-19 Novo Nordisk A/S Method of making proteins in transformed yeast cells
US7795205B2 (en) * 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
EP2044203B1 (de) * 2006-07-14 2013-10-09 Novozymes, Inc. Verfahren für erhöhte genexpression in einer pilzzelle
CN102373216B (zh) * 2011-10-28 2013-06-05 元昊 一种含有医用水蛭素基因的重组真核汉逊酵母工程菌株的构建及重组水蛭素的生产工艺
EP3428282A1 (de) * 2017-07-11 2019-01-16 Alderys Ectoine-herstellende hefe

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940661A (en) * 1984-05-17 1990-07-10 Genentech, Inc. Metallothionein transcription control sequences and use thereof
FR2593518B1 (fr) * 1985-05-02 1989-09-08 Transgene Sa Vecteurs d'expression et de secretion de l'hirudine par les levures transformees
MY101203A (en) * 1985-12-12 1991-08-17 Ucp Gen Pharma Ag Production of thrombin iinhibitors.
MC1834A1 (fr) * 1986-07-10 1988-06-03 Transgene Sa Bloc fonctionnel d'adn et plasmide codant pour l'hirudine,levure transformee,procede de preparation de l'hirudine,hirudine obtenue et son utilisation
AU614959B2 (en) * 1987-05-07 1991-09-19 Commonwealth Scientific And Industrial Research Organisation Expression system
PT88556B (pt) * 1987-09-28 1992-11-30 Smithkline Biolog Processo de integracao genomica estavel e de expressao de uma sequencia de cadificacao estranha, em leveduras
GB8809860D0 (en) * 1988-04-26 1988-06-02 Ciba Geigy Ag Process for production of polypeptides
AU614121B2 (en) * 1988-05-04 1991-08-22 Novartis Ag Improvements in the production of polypeptides
FR2645175B1 (fr) * 1989-03-31 1994-02-18 Transgene Sa Souche de saccharomyces cerevisiaeproductrice d'une proteine heterologue et procede de preparation de ladite proteine heterologue par fermentation de ladite souche

Also Published As

Publication number Publication date
AU675071B2 (en) 1997-01-23
CA2105425A1 (en) 1994-03-05
JP2004000288A (ja) 2004-01-08
DK0592358T3 (da) 2001-02-05
DE69329540T2 (de) 2001-06-07
FI933821L (fi) 1994-03-05
DE69329540D1 (de) 2000-11-16
SG49859A1 (en) 2002-03-19
NO933153D0 (no) 1993-09-03
GR3035201T3 (en) 2001-04-30
ATE196927T1 (de) 2000-10-15
ZA936507B (en) 1994-03-23
HUT67307A (en) 1995-03-28
AU4499493A (en) 1994-03-10
JP3949734B2 (ja) 2007-07-25
HU217094B (hu) 1999-11-29
FI933821A0 (fi) 1993-09-01
EP0592358B1 (de) 2000-10-11
JPH06165691A (ja) 1994-06-14
HU9302503D0 (en) 1993-11-29
US5726043A (en) 1998-03-10
ES2152943T3 (es) 2001-02-16
IL106897A0 (en) 1993-12-28
PT592358E (pt) 2001-03-30
EP0592358A2 (de) 1994-04-13
FI933821A7 (fi) 1994-03-05
MX9305375A (es) 1994-03-31
NZ248558A (en) 1995-04-27
EP1031628A1 (de) 2000-08-30
EP0592358A3 (en) 1994-09-28
KR940007180A (ko) 1994-04-26

Similar Documents

Publication Publication Date Title
EP0814154A3 (de) Rekombinante Alphavirus-Vektoren
NO871785D0 (no) Fremgangsmaate for fremstilling av et proteinprodukt, samt vektorsystem for fremgangsmaatens utfoerelse.
AU5421594A (en) Recombinant method and host for manufacture of xylitol
ATE109829T1 (de) Interleukin-7.
ATE107360T1 (de) Expression von menschlichen apolipoproteinen ai- milano in hefe.
NO933153L (no) Fremgangsmåte for fremstilling av protease-inhibitorer
BG50281A3 (bg) Метод за получаване на рекомбинантн днк експресионен вектор
WO1994026925A3 (en) Processes for producing an enzyme
IT1250692B (it) Procedimento per la preparazione di demetilepipodofillotossina- beta-d-glucosidi.
PT87230A (pt) Process for the production of proteins
AU5971090A (en) Metalloproteinase inhibitor sequence recombinant vector system for using same and recombinant-dna method for the manufacture of same
NO944846L (no) Fremgangsmåte for fremstilling av protein C
AU2253288A (en) Expression vectors for the synthesis of proteins and plasmid replicons and sequence cassettes for use in constructing such vectors
AU2190288A (en) Vector for the expression of proteins of the HIV-2 virus, one of the casual agents of AIDS, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained
NO942531L (no) Fremgangsmåte for fremstilling av 3-acylöstratriener og acylbenzener
ATE153379T1 (de) Expression von proteinsüssmitteln in hefe
FR2661188B1 (fr) Nouveaux vecteurs de clonage et/ou d'expression, procede de preparation et leur utilisation.
AU5239290A (en) Purification of c.pseudotuberculosis toxin, and cloning and expression of toxin gene
NZ332555A (en) Gene expression in monocytes and macrophages associated with the CD68 gene
AP9600790A0 (en) Process for preparation of substituted steroidal dienes and novel intermediates used in said process.
EP0197797A3 (en) Improved recombinant hosts, their production and use
ES8605574A1 (es) Procedimiento para preparar una alcoholdeshidrogenasa

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application